The 2% device growth in the US should be read within the context the US market is at a more mature stage and shifting towards the Software-as-a-Service revenue market represented by a much stronger 23% growth in the Masks and other category. This is a positive move towards the SAAS category?
Ann: ResMed Announces Results for the First Quarter of FY2024, page-30
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.88 |
Change
-0.720(1.91%) |
Mkt cap ! $23.36B | |||
| Open | High | Low | Value | Volume |
| $37.36 | $37.42 | $36.84 | $54.23M | 1.466M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11087 | $36.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.90 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| RMD (ASX) Chart |